Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 3/20 | 0.42 |
| ▸ | CES1 | P23141 | 3/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | VRK1 | Q99986 | 2/20 | 0.37 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27540052 | 0.97 | ERN1 (0.54) | ERN1CA9CA12CA1IDO1 | |
| SCHEMBL5513552 | 0.87 | ERN1 (0.52) | ERN1CA9CA12CA1IDO1 | |
| SCHEMBL8059874 | 0.84 | IDO1 (0.55) | ERN1CA9CA12CA1IDO1 | |
| Trifluoroacetic Acid SCHEMBL30390569 | 0.80 | ERN1 (0.52) | ERN1CA9CA12CA1IDO1 | |
| SCHEMBL5315670 | 0.80 | ERN1 (0.46) | ERN1CA9CA12CA1IDO1 | |
| SCHEMBL104581 | 0.80 | ERN1 (0.46) | ERN1CA9CA12CA1IDO1 | |
| SCHEMBL815794 | 0.80 | ERN1 (0.46) | ERN1CA9CA12CA1IDO1 | |
| SCHEMBL1521925 | 0.80 | ERN1 (0.46) | ERN1CA9CA12CA1IDO1 | |
| SCHEMBL1155741 | 0.80 | ERN1 (0.46) | ERN1CA9CA12CA1IDO1 | |
| SCHEMBL5399616 | 0.80 | ERN1 (0.46) | ERN1CA9CA12CA1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 913 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025149479-A1 | SYNTHESIS OF MODIFIED NUCLEOSIDE TRIPHOSPHATES | ROCHE DIAGNOSTICS GMBH (DE) | 2025-07-17 | — | — | WO | claimed |
| US-11485806-B2 | Process for the preparation of polymerized polyethylene wax | SCG CHEMICALS CO., LTD. (TH) | 2022-11-01 | — | — | US | claimed |
| CN-113214623-A | Preparation method of phosphorus-halogen synergistic flame-retardant unsaturated polyester resin material | 中国科学技术大学 | 2021-08-06 | — | — | CN | claimed |
| EP-3318544-B1 | PROCESS FOR THE PREPARATION OF POLYMERIZED POLYETHYLENE WAX | SCG CHEMICALS CO LTD (TH) | 2020-03-18 | — | — | EP | claimed |
| US-20190263947-A1 | PROCESS FOR THE PREPARATION OF POLYMERIZED POLYETHYLENE WAX | SCG CHEMICALS CO., LTD. (TH) | 2019-08-29 | — | — | US | claimed |
| EP-3318544-A1 | PROCESS FOR THE PREPARATION OF POLYMERIZED POLYETHYLENE WAX | Scg Chemicals Co. Ltd. (TH) | 2018-05-09 | — | — | EP | claimed |
| CN-102809559-B | Method for detecting halogenated aromatic organic matter | RES CT ECO ENVIRONMENTAL SCIEN | 2015-06-17 | — | — | CN | claimed |
| US-20140288249-A1 | Methods for Producing Polyolefins With Catalyst Systems | UNIVATION TECHNOLOGIES, LLC (US) | 2014-09-25 | — | — | US | claimed |
| EP-2776476-A1 | METHODS FOR PRODUCING POLYOLEFINS WITH CATALYST SYSTEMS | Univation Technologies, LLC (US) | 2014-09-17 | — | — | EP | claimed |
| WO-2013070602-A1 | METHODS FOR PRODUCING POLYOLEFINS WITH CATALYST SYSTEMS | UNIVATION TECHNOLOGIES, LLC (US) | 2013-05-16 | — | — | WO | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| EP-1066269-B1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2005-05-11 | — | — | EP | claimed |
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | DAEYAERT FREDERIK FRANS DESIRE (BE) | 2002-08-22 | — | — | US | claimed |
| US-6333388-B1 | Aluminum compound-containing solid catalyst component, catalyst for olefin polymerization and method for producing olefin polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-12-25 | — | — | US | claimed |
| EP-1066269-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-01-10 | — | — | EP | claimed |
| US-6150360-A | ADMINISTERING TO A PATIENT SUFFERING FROM HUMAN IMMUNODEFICIENCY VIRUS INFECTION A TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVE | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-11-21 | — | — | US | claimed |
| US-6100213-A | Aluminum compound-containing solid catalyst component, catalyst for olefin polymerization and method for producing olefin polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-08-08 | — | — | US | claimed |
| WO-1999050256-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-10-07 | — | — | WO | claimed |
| WO-1996012723-A1 | PROCESS FOR PREPARING ALKYLSILYL OR ARYLSILYL ETHERS | FMC CORPORATION (US) | 1996-05-02 | — | — | WO | claimed |
| US-5493044-A | Process for preparing alkylsilyl or arylsilyl ethers | FMC CORPORATION (US) | 1996-02-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | XDH, CCR5, CXCR1 | ERN1 703/4885CA9 4825/4885CA12 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.